Guillain-Barré syndrome associated with minimal change glomerulopathy and tubular dysfunction - Related to acetone-based organic solvent?

American Journal of Nephrology

Volumn 22, Issue 5-6, 2002, Pages 560-565

  Chen, Jiann Keh ^a   Wu, Mai Szu ^a   Yang, Chih Wei ^a   Huang, Jeng Yi ^a   Hsu, Po Yaur ^a   Lin, Chun Liang ^a   Huang, Chiu Ching ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Acetone; Guillain Barr syndrome; Minimal change nephrotic syndrome; Renal tubular dysfunction

Indexed keywords

ACETONE; ORGANIC SOLVENT; PREDNISOLONE; PROTON PUMP; SODIUM POTASSIUM CHLORIDE COTRANSPORTER;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ELECTRON MICROSCOPY; FEMALE; GUILLAIN BARRE SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; LABORATORY TEST; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; NEPHROTOXICITY; NEUROLOGIC DISEASE; NEUROTOXICITY; OCCUPATIONAL EXPOSURE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBULAR DYSFUNCTION;

ACETONE; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; NEPHROSIS, LIPOID; OCCUPATIONAL EXPOSURE; SOLVENTS;

EID: 0036979994     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065268     Document Type: Article

References (13)

1. Smulders YM, Jos Frissen PH, Slaats EH, Silberbusch J: Renal tubular acidosis. Pathophysiology and diagnosis. Arch Intern Med 1996; 156:1629-1636.
2. Satoh T, Omae K, Nakashima H, et al: Relationship between acetone exposure concentration and health effects in acetate fiber plant workers. Int Arch Occup Environ Health 1996;68:147-153.
3. Jones AW: Elimination half-life of acetone in humans: Case reports and review of the literature. J Anal Toxicol 2000;24:8-10.
4. Dick RB, Brown WD, Setzer JV, et al: Effect of short-duration exposure to acetone and methyl ethyl ketone. Toxicol Lett 1988;43:31-49.
5. Asbury AK, Cornblath DR: Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S21-S24.
6. Lin CL, Wu MS, Yang CW, Huang CC: Leptospirosis associated with hypokalemia and thick ascending limb dysfunction. Nephrol Dial Transplant 1999;14:193-195.
7. Wu MS, Hong JJ, Lin JL, Yang CW, Chien HC: Multiple tubular dysfunctions induced by mixed Chinese herbal medicines containing cadmium. Nephrol Dial Transplant 1996;11:867-870.
8. Murphy BF, Gonzales MF, Ebeling P, Fairley KF, Kincaid-Smith P: Membranous glomerulonephritis and Landry-Guillain-Barré syndrome. Am J Kidney Dis 1986;8:267-270.
9. Kitamura H, Nakano T, Kakihara M, et al: A case of Guillan-Barré syndrome developed minimal change nephrotic syndrome simultaneously. Am J Nephrol 1998;18:151-154.
10. Careless D, Rigby R, Axelsen R, et al: A case of Guillain-Barré syndrome with focal segmental glomerulosclerosis. Am J Nephrol 1993;13:160-163.
11. Olbricht CJ, Stark E, Helmchen U, et al: Glomerulonephritis associated with inflammatory demyelinating polyradiculoneuropathy: A case report and review of the literature. Nephron 1993;64:139-141.
12. D'Allesandro R, Casmiro M, Guarino M: Risk factors for Guillain-Barré sndrome: A population-based case-control study. Neurology 1999;246:1004-1009.
13. Schrier RW, Gottschalk CW: Diseases of the Kidney. New York, Little Brown, 1997, pp 1991-2001.